NCT05571319View on ClinicalTrials.gov

A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 11, 2022

Primary Completion Date

March 24, 2025

Study Completion Date

March 28, 2025

Conditions
Metabolic SyndromeHIV Seropositivity
Interventions
DRUG

Metformin Extended Release Oral Tablet

Glucophage XR 500 mg

Trial Locations (1)

8001

Desmond Tutu Health Foundation: Gugulethu Research Site, Cape Town

All Listed Sponsors
collaborator

University of Rochester

OTHER

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

University of Stellenbosch

OTHER